RESUMO
OBJECTIVE: To optimize the patient dose and image quality through quality assurance (QA) of diagnostic x-ray equipment and to ensure compliance with international and national standards in x-ray specification parameters, the use of contactless and quick non-invasive instruments has gained importance. Considering the importance of equipment qualification and the intervention level for equipment management, it is vital to account for uncertainties in the measurement of parameters in diagnostic radiology. However, the limits and measurement uncertainties associated with the parameter measurement are not well established and many technical and scientific literature provide different tolerance values, either as absolute or in terms of percentage. METHODS AND MATERIALS: In this paper, the authors analyze non-invasive multi-parameter detector measurements with the aim to (i) improve the accuracy in measurement of x-ray parameters (kilovoltage, dose, and exposure time); (ii) estimate the uncertainty associated with such measurements; (iii) analyze the tolerance values prescribed by various professional and regulatory bodies and propose an improvised method of reporting the parameters. The approach adopted in this paper takes into account the uncertainties associated with traditional instruments and the subjectivity in the measurements. RESULTS: Estimated uncertainty for kV measurements in the range between 1.45 kV at 40 kV measurements and 4.88 kV at 150 kV measurements. The MU associated with the dose measurement is estimated to be 6.2% at 110 kVp, 100 mA, and 500 msec. Maximum MU estimated at 10 msec exposure time is 4.5% and with MU of 5% deviation added to 9.5%. CONCLUSIONS: The current practice of reporting the measured mean values deviation without considering the inherent measurement uncertainty may not be a correct quantification procedure in QA. This is evident from the case study that 3% addition to the measured kV, 6.2% addition in the measured dose, and 4.5% to the measured time accounts for measurement uncertainty.
RESUMO
With an objective to establish adult diagnostic reference levels in the practice of nuclear medicine (NM) in the state of Tamil Nadu (TN), data on the predominant NM procedures carried out in the state are analyzed. In this study, data on total NM diagnostic procedures during the years 2015-19 along with patient-specific diagnostic NM procedure data for the period April-June 2021 from all centers in Tamil Nadu are collected and analyzed using SPSS statistical software. Nine predominant types of NM scans are analyzed. Collective effective dose from NM scans and per capita dose for the TN population are estimated. The 75th percentile of the distribution and average administered activity (AAA) has been derived and local reference levels are reported. Based on the statistical analysis, it is observed that the whole-body positron emission tomography (PET), renal diethylenetriamine pentaacetate (DTPA) scan, bone methylene diphosphonate (MDP) scan, iodine-131 whole body scan, thyroid studies using Technetium per technetate, renal dimercaptosuccinic acid (DMSA), myocardial perfusion methoxyisobutyl isonitrile sestamibi (MIBI), mebrofenin, Galium-68 prostate-specific membrane antigen (PSMA) are the most common procedure covering >90% of the practices carried out. The collective effective dose is 410 man-Sv in the year 2019, leading to a mean effective dose of 0.006 mSv per capita of the TN state population. The 75th percentile of the distribution of AA is slightly higher than diagnostic reference level (DRL) as compared with Australian DRL (310 MBq). It is also observed that F-18 PET procedures are primarily responsible for most of the collective effective dose, local DRL is 316 MBq and it is important to establish national DRLs for NM diagnostic scans to optimize the NM examinations.
